The Saudi Arabia pharmaceutical market was valued at USD 11.0 billion in 2025, is estimated at USD 11.7 billion in 2026, is projected to reach USD 21.6 billion by 2036 and is forecast to register a 6.3% CAGR between 2026 and 2036. In 2026, prescription products hold 61.6% within the product type segment.